Results 231 to 240 of about 75,591 (303)

Access to Medications for Opioid Use Disorder Among Veterans With Homeless Experience in Permanent Supportive Housing.

JAMA Netw Open
Hsu M, Panadero T, Mooney LJ, Kim D, Lawrence D, Yuan A, Siddarth P, Gabrielian S.   +7 more
europepmc   +1 more source

"We're All in This Together": A Mixed-Methods Study of Provider and Patient Perceptions of Emergency Care for Opioid Use Disorder. [PDF]

J Adv Nurs
McFarland A, Chan L, Lalwani P, Chapman BP, Davis-Martin R, Kapadia N, Carreiro S.   +6 more
europepmc   +1 more source

Improving access to direct acting antivirals via a multimodal integrated care program in an addiction medicine clinic

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Injection drug use is a driver of hepatitis C virus (HCV) transmission, thus integrating HCV care into addiction care is likely necessary for HCV elimination. Here we describe how we integrated HCV care into our addiction medicine (AM) clinic and evaluate its effect on HCV treatment.
Arya Zandvakili, Joseph Rattenni, James Burton, Lakshmi Guduguntla, Marcus Osman, Sayeh Sabbagh, Stephan Arndt, Ben Miskle, Quanhathai Kaewpoowat, Michael Ohl, Andrea Weber, Alison Lynch   +11 more
wiley   +1 more source

Factors Associated With Adult Incarceration Among People With Opioid Use Disorder in New South Wales, Australia. [PDF]

Drug Alcohol Rev
Macdonald C, Bharat C, Degenhardt L, Hickman M, Stone J, Sutherland R, Harrod M, Grebely J, Santo T.   +8 more
europepmc   +1 more source

Brief Report: Opioid‐related disorders increase patient‐directed discharge in admissions for hemorrhagic or ischemic stroke

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Opioid use has been linked to increased stroke incidence and severity; however, data on effects during acute stroke hospitalization are limited. Methods We used the 2016–2020 National Inpatient Sample to evaluate the effects of opioid disorders on patient‐directed discharge (PDD) and length of stay (LOS) in 3,101,545 ...
Rohan M. Shah, Shiv Patel, Brent Schnipke, Brandon Hamm   +3 more
wiley   +1 more source

A lifeline on wheels: perspectives of stakeholders on the implementation and impact of a mobile medications for opioid use disorder unit. [PDF]

Addict Sci Clin Pract
Kang A, Bailey A, Hurley L, Martin R.
europepmc   +1 more source

Factors associated with readmission to residential treatment among clients transitioned from detoxification services in Alberta, Canada

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Readmission to residential treatment increases healthcare costs, strains publicly funded systems, and may not adequately meet clients' needs. This study examined rates and predictors of readmission to residential treatment among clients transitioned from detoxification services.
Abreham Mekonnen
wiley   +1 more source

Older Age Is Associated With Long-Term Retention in Buprenorphine Treatment for Opioid Use Disorder. [PDF]

J Am Geriatr Soc
Groeger JL, Lu T, Jakubowski A, Zhang C, Deng Y, Perez H, DiRenno F, Jadow BM, Hayes BT, Nahvi S, Cunningham CO, Starrels JL.   +11 more
europepmc   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter, I. M. Adcock, C. Benito‐Villalvilla, R. Bianchini, L. Bjermer, G. Caramori, L. Cari, K. F. Chung, Z. Diamant, I. Eguiluz‐Gracia, E. F. Knol, M. Jesenak, F. Levi‐Schaffer, G. Nocentini, L. O'Mahony, O. Palomares, F. Redegeld, M. Sokolowska, B. Van Esch, M. Zurlo, C. Stellato   +20 more
wiley   +1 more source